Trials / Unknown
UnknownNCT02580006
To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers
A Randomized, Double-blind, Active Control, Single Dosing, Crossover Clinical Trial to Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This Phase I study is to compare pharmacokinetics, safety and pharmacodynamics of EPORON and EPREX after single subcutaneous administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EPORON | single dose administration subcutaneously |
| DRUG | EPREX | single dose administration subcutaneously |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-01-01
- Completion
- 2016-03-01
- First posted
- 2015-10-20
- Last updated
- 2015-10-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02580006. Inclusion in this directory is not an endorsement.